α-melanocyte-stimulating hormone protects against mesenteric ischemia-reperfusion injury

Heitham T Hassoun, Lei Zou, Frederick A. Moore, Rosemary A. Kozar, Norman W. Weisbrodt, Bruce C. Kone

Research output: Contribution to journalArticle

Abstract

Mesenteric ischemia-reperfusion (I/R) injury to the intestine is a common and often devastating clinical occurrence for which there are few therapeutic options. α-Melanocyte-stimulating hormone (α-MSH) is a tridecapeptide released by the pituitary gland and immunocompetent cells that exerts antiinflammatory actions and abrogates postischemic injury to the kidneys and brainstem of rodents. To test the hypothesis that α-MSH would afford similar protection in the postischemic small intestine, we analyzed the effects of this peptide on intestinal transit, histology, myeloperoxidase activity, and nuclear factor-κB (NF-κB) activation after 45 min of superior mesenteric artery occlusion and ≤6 h of reperfusion. Rats subjected to I/R exhibited markedly depressed intestinal transit, histological evidence of severe injury to the ileum, increased myeloperoxidase activity in ileal cytoplasmic extracts, and biphasic activation of NF-κB in ileal nuclear extracts. In contrast, rats treated with α-MSH before I/R exhibited intestinal transit and histological injury scores comparable to those of sham-operated controls. In addition, the α-MSH-treated rats demonstrated less I/R-induced activation of intestinal NF-κB and myeloperoxidase activity after prolonged (6 h) reperfusion. We conclude that α-MSH significantly limits postischemic injury to the rat small intestine.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Gastrointestinal and Liver Physiology
Volume282
Issue number6 45-6
StatePublished - 2002
Externally publishedYes

Fingerprint

Melanocyte-Stimulating Hormones
Reperfusion Injury
Reperfusion
Peroxidase
Ischemia
Wounds and Injuries
Small Intestine
Superior Mesenteric Artery
Pituitary Gland
Ileum
Brain Stem
Intestines
Rodentia
Histology
Anti-Inflammatory Agents
Mesenteric Ischemia
Kidney
Peptides

Keywords

  • Ileus
  • Nuclear factor-κB
  • Small intestine
  • Transcription factor

ASJC Scopus subject areas

  • Gastroenterology
  • Physiology

Cite this

Hassoun, H. T., Zou, L., Moore, F. A., Kozar, R. A., Weisbrodt, N. W., & Kone, B. C. (2002). α-melanocyte-stimulating hormone protects against mesenteric ischemia-reperfusion injury. American Journal of Physiology - Gastrointestinal and Liver Physiology, 282(6 45-6).

α-melanocyte-stimulating hormone protects against mesenteric ischemia-reperfusion injury. / Hassoun, Heitham T; Zou, Lei; Moore, Frederick A.; Kozar, Rosemary A.; Weisbrodt, Norman W.; Kone, Bruce C.

In: American Journal of Physiology - Gastrointestinal and Liver Physiology, Vol. 282, No. 6 45-6, 2002.

Research output: Contribution to journalArticle

Hassoun, Heitham T ; Zou, Lei ; Moore, Frederick A. ; Kozar, Rosemary A. ; Weisbrodt, Norman W. ; Kone, Bruce C. / α-melanocyte-stimulating hormone protects against mesenteric ischemia-reperfusion injury. In: American Journal of Physiology - Gastrointestinal and Liver Physiology. 2002 ; Vol. 282, No. 6 45-6.
@article{82dfe796b1ad4382bad9bc4a2757b6b1,
title = "α-melanocyte-stimulating hormone protects against mesenteric ischemia-reperfusion injury",
abstract = "Mesenteric ischemia-reperfusion (I/R) injury to the intestine is a common and often devastating clinical occurrence for which there are few therapeutic options. α-Melanocyte-stimulating hormone (α-MSH) is a tridecapeptide released by the pituitary gland and immunocompetent cells that exerts antiinflammatory actions and abrogates postischemic injury to the kidneys and brainstem of rodents. To test the hypothesis that α-MSH would afford similar protection in the postischemic small intestine, we analyzed the effects of this peptide on intestinal transit, histology, myeloperoxidase activity, and nuclear factor-κB (NF-κB) activation after 45 min of superior mesenteric artery occlusion and ≤6 h of reperfusion. Rats subjected to I/R exhibited markedly depressed intestinal transit, histological evidence of severe injury to the ileum, increased myeloperoxidase activity in ileal cytoplasmic extracts, and biphasic activation of NF-κB in ileal nuclear extracts. In contrast, rats treated with α-MSH before I/R exhibited intestinal transit and histological injury scores comparable to those of sham-operated controls. In addition, the α-MSH-treated rats demonstrated less I/R-induced activation of intestinal NF-κB and myeloperoxidase activity after prolonged (6 h) reperfusion. We conclude that α-MSH significantly limits postischemic injury to the rat small intestine.",
keywords = "Ileus, Nuclear factor-κB, Small intestine, Transcription factor",
author = "Hassoun, {Heitham T} and Lei Zou and Moore, {Frederick A.} and Kozar, {Rosemary A.} and Weisbrodt, {Norman W.} and Kone, {Bruce C.}",
year = "2002",
language = "English (US)",
volume = "282",
journal = "American Journal of Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "6 45-6",

}

TY - JOUR

T1 - α-melanocyte-stimulating hormone protects against mesenteric ischemia-reperfusion injury

AU - Hassoun, Heitham T

AU - Zou, Lei

AU - Moore, Frederick A.

AU - Kozar, Rosemary A.

AU - Weisbrodt, Norman W.

AU - Kone, Bruce C.

PY - 2002

Y1 - 2002

N2 - Mesenteric ischemia-reperfusion (I/R) injury to the intestine is a common and often devastating clinical occurrence for which there are few therapeutic options. α-Melanocyte-stimulating hormone (α-MSH) is a tridecapeptide released by the pituitary gland and immunocompetent cells that exerts antiinflammatory actions and abrogates postischemic injury to the kidneys and brainstem of rodents. To test the hypothesis that α-MSH would afford similar protection in the postischemic small intestine, we analyzed the effects of this peptide on intestinal transit, histology, myeloperoxidase activity, and nuclear factor-κB (NF-κB) activation after 45 min of superior mesenteric artery occlusion and ≤6 h of reperfusion. Rats subjected to I/R exhibited markedly depressed intestinal transit, histological evidence of severe injury to the ileum, increased myeloperoxidase activity in ileal cytoplasmic extracts, and biphasic activation of NF-κB in ileal nuclear extracts. In contrast, rats treated with α-MSH before I/R exhibited intestinal transit and histological injury scores comparable to those of sham-operated controls. In addition, the α-MSH-treated rats demonstrated less I/R-induced activation of intestinal NF-κB and myeloperoxidase activity after prolonged (6 h) reperfusion. We conclude that α-MSH significantly limits postischemic injury to the rat small intestine.

AB - Mesenteric ischemia-reperfusion (I/R) injury to the intestine is a common and often devastating clinical occurrence for which there are few therapeutic options. α-Melanocyte-stimulating hormone (α-MSH) is a tridecapeptide released by the pituitary gland and immunocompetent cells that exerts antiinflammatory actions and abrogates postischemic injury to the kidneys and brainstem of rodents. To test the hypothesis that α-MSH would afford similar protection in the postischemic small intestine, we analyzed the effects of this peptide on intestinal transit, histology, myeloperoxidase activity, and nuclear factor-κB (NF-κB) activation after 45 min of superior mesenteric artery occlusion and ≤6 h of reperfusion. Rats subjected to I/R exhibited markedly depressed intestinal transit, histological evidence of severe injury to the ileum, increased myeloperoxidase activity in ileal cytoplasmic extracts, and biphasic activation of NF-κB in ileal nuclear extracts. In contrast, rats treated with α-MSH before I/R exhibited intestinal transit and histological injury scores comparable to those of sham-operated controls. In addition, the α-MSH-treated rats demonstrated less I/R-induced activation of intestinal NF-κB and myeloperoxidase activity after prolonged (6 h) reperfusion. We conclude that α-MSH significantly limits postischemic injury to the rat small intestine.

KW - Ileus

KW - Nuclear factor-κB

KW - Small intestine

KW - Transcription factor

UR - http://www.scopus.com/inward/record.url?scp=0036083286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036083286&partnerID=8YFLogxK

M3 - Article

VL - 282

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0363-6135

IS - 6 45-6

ER -